Search results for "STAGE"

showing 10 items of 1393 documents

Recurrence of esophageal cancer after R0 surgery: risk factors and evolution

2013

Introduction despite advances in surgical and adjuvant therapy, recurrence in esophageal cancer submitted to R0 surgery remains high. The aim is to define risk factors and recurrence patterns. Additionally, to show the management carried out and the outcome of patients showing recurrence. Material and methods observational and prospective study that included 61 patients. Neoadjuvancy therapy was indicated on T3, T4 and N+ tumors and every lymph node dissection was performed in two fields. Recurrence is defined at distance, regional or local, when, recurrence is detected after six months. According to clinical features and the recurrences, a palliative, chemotherapeutic or surgical managemen…

Malemedicine.medical_specialtyEsophageal NeoplasmsEsophageal cancerRecurrenciaCurative esophagectomyPrognostic factorsRecurrenceRisk FactorsAdjuvant therapymedicineHumansProspective StudiesStage (cooking)Risk factorlcsh:RC799-869Prospective cohort studyLymph nodeCáncer de esófagobusiness.industryEsofaguectomía curativaGastroenterologyGeneral MedicineMiddle AgedEsophageal cancermedicine.diseaseSurgeryDissectionTreatment Outcomemedicine.anatomical_structureFemalelcsh:Diseases of the digestive system. GastroenterologyLymphNeoplasm Recurrence LocalbusinessFactores pronósticoRevista Espanola de Enfermedades Digestivas
researchProduct

End-Stage Pancreatic Adenocarcinoma Presenting as a Sister Mary Joseph's Nodule.

2017

[No abstract available]

Malemedicine.medical_specialtyFatal outcomeSkin NeoplasmsAdenocarcinomaDiagnosis Differential03 medical and health sciences0302 clinical medicineFatal OutcomeX ray computedMedicineHumansStage (cooking)Sister Mary Joseph's NoduleNeoplasm StagingUmbilicusbusiness.industryGeneral MedicineMiddle Agedmedicine.diseasePancreatic Neoplasms030220 oncology & carcinogenesisAdenocarcinoma030211 gastroenterology & hepatologyNeoplasm stagingRadiologybusinessTomography X-Ray Computedpancreatic adenocarcinoma sister Mary Joseph's noduleBiomarkersThe American surgeon
researchProduct

Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.

2009

To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded.LVH was observed in 47.1% of patients with CKD and in 31.14% of essential hypertensive patients (P0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2 to 5 CKD. Distribution of concentric and eccentric LVH was not different between the two groups. H…

Malemedicine.medical_specialtyHeart diseasePhysiologyRenal functionGuidelines as TopicLeft ventricular hypertrophyMuscle hypertrophyElectrolytesCatecholaminesInternal medicineReninInternal MedicinemedicineDiabetes MellitusPrevalenceHumansLeft ventricular geometrycardiovascular diseasesStage (cooking)AldosteroneAgedbusiness.industryCase-control studyBlood Pressure DeterminationMiddle Agedmedicine.diseaseEchocardiography DopplerItalyCase-Control StudiesCreatinineChronic DiseaseHypertensionCardiologyRegression AnalysisFemaleHypertrophy Left VentricularKidney DiseasesNefropatie croniche ipertrofia ventricolare sinistra ipertensione arteriosaCardiology and Cardiovascular MedicinebusinessKidney diseaseGlomerular Filtration RateJournal of hypertension
researchProduct

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Resul…

2018

Abstract Background and purpose Standard treatment of epidermoid anal cancer is 5-fluorouracil (5FU) and mitomycin C (MMC) based chemoradiotherapy (CRT). This phase I study aims to evaluate the addition of panitumumab (Pmab) to CRT and to determine the maximum tolerated dose (MTD) of Pmab and 5-FU in combination with CRT. Materials and methods Immunocompetent patients with locally advanced tumour without metastases (Stage T2, T3 or T4, whatever N stage; Stage N1–N3 whatever T stage) followed two RT periods (45 Gy in 5 weeks and 20 Gy in 2 weeks, separated by a 2-week break) with concomitant CT sessions of 5FU/MMC at RT weeks 1, 5 and 8. Pmab was administered on RT weeks 1, 3, 5, 8 and 10 ac…

Malemedicine.medical_specialtyMitomycinUrologyPhases of clinical research030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAnal cancerPanitumumabRadiology Nuclear Medicine and imagingProspective StudiesAgedbusiness.industryPanitumumabStandard treatmentMitomycin CChemoradiotherapyHematologyMiddle AgedAnus Neoplasmsmedicine.diseaseErbB ReceptorsOncology030220 oncology & carcinogenesisConcomitantT-stageFemaleFluorouracilbusinessChemoradiotherapymedicine.drugRadiotherapy and Oncology
researchProduct

Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry

2019

Background Infants diagnosed with stage 4 s neuroblastoma commonly experience spontaneous disease regression, with few succumbing without response to therapy. We analyzed a large cohort of such infants enrolled in the Italian Neuroblastoma Registry to detect changes over time in presenting features, treatment and outcome. Methods Of 3355 subjects aged 0–18 years with previously untreated neuroblastoma diagnosed between 1979 and 2013, a total of 280 infants (8.3%) had stage 4 s characteristics, 268 of whom were eligible for analyses. Three treatment eras were identified on the basis of based diagnostic and chemotherapy adopted. Group 1 patients received upfront chemotherapy; Group 2 and 3 pa…

Malemedicine.medical_specialtyMultivariate analysisAdolescentmedicine.medical_treatmentLiver transplantationPrognostic factorsPediatricsCohort Studies03 medical and health sciencesNeuroblastoma0302 clinical medicineStage 4 s030225 pediatricsInternal medicineNeuroblastomamedicineHumansRegistries030212 general & internal medicineElevated ldhStage (cooking)Risk factorChildMale genderStage 4 sNeoplasm StagingChemotherapybusiness.industryResearchInfant Newbornlcsh:RJ1-570Infantlcsh:PediatricsPerinatology and Child Healthmedicine.diseaseSurvival RateInfants; Neuroblastoma; Prognostic factors; Stage 4 s; Pediatrics Perinatology and Child HealthItalyChild PreschoolFemalebusinessInfantsItalian Journal of Pediatrics
researchProduct

REM sleep behavior disorder and periodic leg movements during sleep in ALS

2017

Objective To assess sleep characteristics and the occurrence of abnormal muscle activity during sleep, such as REM sleep without atonia (RSWA), REM sleep behavior disorder (RBD), and periodic leg movements during sleep (PLMS), in patients with amyotrophic lateral sclerosis (ALS). Methods A total of 41 patients with ALS and 26 healthy subjects were submitted to clinical interview and overnight video-polysomnography. Results A total of 22 patients with ALS (53.6%) reported poor sleep quality. Polysomnographic studies showed that patients with ALS had reduced total sleep time, increased wakefulness after sleep onset, shortened REM and slow-wave sleep, and decreased sleep efficiency, compared t…

Malemedicine.medical_specialtyNeurologyperiodic leg movementPolysomnography[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologySleep StagePolysomnographyREM Sleep Behavior Disorderrapid eye movement sleep without atoniaNon-rapid eye movement sleepREM sleep behavior disorder03 medical and health sciences0302 clinical medicineInsomniamedicineHumansamyotrophic lateral sclerosisleepComputingMilieux_MISCELLANEOUSSlow-wave sleepAgedmedicine.diagnostic_test[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior[SCCO.NEUR]Cognitive science/NeuroscienceAmyotrophic Lateral Sclerosis[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesGeneral MedicineMiddle Agedmedicine.diseaseSleep in non-human animals3. Good healthNocturnal Myoclonus Syndrome030228 respiratory systemItalyNeurologyAnesthesiarapid eye movement sleep behavior disorderFemaleSettore MED/26 - NeurologiaSleep StagesNeurology (clinical)medicine.symptomSleep onsetPsychology030217 neurology & neurosurgeryHuman
researchProduct

Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain

2011

Objective: The objective of this study was to define the clinical characteristics of osteonecrosis of the jaws (ONJ) induced by oral bisphosphonates in a series of patients from a circumscribed area in northwest Spain. Study Design:A retrospective multicentre study was undertaken in 3 hospitals in an area with a radius less than 100 km in the Autonomous Community of Galicia (Spain). The medical records were reviewed and an oral examination was performed of patients diagnosed with oral bisphosphonate-related ONJ in the previous 3 years. Results: We detected 20 cases of ONJ (24 lesions) related to oral bisphosphonates (alendronate [16 patients] and ibandronate [4 patients]), which were mainly…

Malemedicine.medical_specialtyOsteoporosisCorticosteroid treatmentDiabetes mellitusmedicineHumansStage (cooking)Ibandronic AcidGeneral DentistryAgedRetrospective StudiesAged 80 and overSeries (stratigraphy)Oral Medicine and PathologyOral bisphosphonatesAlendronateBone Density Conservation AgentsDiphosphonatesbusiness.industryMedical recordMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurgeryOtorhinolaryngologySpainUNESCO::CIENCIAS MÉDICASOral examinationBisphosphonate-Associated Osteonecrosis of the JawFemaleResearch-ArticleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit

2017

Background: Delirium is often unrecognized in cancer patients. The aim of this study was to investigate the prevalence of delirium assessed by the Memorial Delirium Assessment Scale (MDAS) and possible associated factors on admission to an acute palliative/supportive care unit (APSCU). The secondary outcome was to assess changes in MDAS and symptom burden at time of discharge. Methods: A consecutive sample of advanced cancer patients who were admitted to an APSCU was prospectively assessed for a period of 10 months. Patient demographics, including age, gender, primary diagnosis, Karnofsky status, stage of disease, and educational level were collected. The Edmonton Symptom Assessment Scale (…

Malemedicine.medical_specialtyPalliative careDiseaseCONSECUTIVE SAMPLE03 medical and health sciences0302 clinical medicineNeoplasmsAdvanced cancerparasitic diseasesmedicinePrevalenceHumans030212 general & internal medicineKarnofsky Performance StatusStage (cooking)Intensive care medicineReferral and ConsultationAgedAged 80 and overpalliative carebusiness.industryMedicine (all)edmonton symptom assessment scaleCancerDeliriummemorial delirium assessment scaleGeneral MedicineAssessment scaleLength of StayMiddle Agedmedicine.diseaseAdvanced cancerPatient DischargeHospitalization030220 oncology & carcinogenesisEmergency medicineDeliriumNeoplasmFemaleKarnofsky Performance Statumedicine.symptombusinessHuman
researchProduct

Characteristics of patients with an unplanned admission to an acute palliative care unit

2016

The aim of this cohort study is to compare the symptom burden of patients who have an unplanned admission to an acute palliative care unit (APCU) with patients who have a regular planned admission. A consecutive sample of advanced cancer patients who were admitted to an APCU was prospectively assessed. The reasons and the kind of admission were recorded (unplanned, UP, or planned, P). Anticancer treatments, whether patients were on/off treatment or uncertain, previous care setting, and who referred the patient to the unit were also recorded. The Edmonton Symptom Assessment Scale (ESAS) was used at admission and at time of discharge, as well as the Memorial Delirium Assessment Scale. Analges…

Malemedicine.medical_specialtyPalliative careReferralDiseaseCohort Studies03 medical and health sciencesEarly palliative care0302 clinical medicineRetrospective StudieNeoplasmsInternal MedicinemedicineHumans030212 general & internal medicineStage (cooking)Unplanned admissionQualitative ResearchCancerAgedRetrospective Studiesbusiness.industryMortality ratePalliative CareMiddle AgedSymptom Flare UpHospitalization030220 oncology & carcinogenesisEmergencyEmergency medicineEmergency MedicineNeoplasmDeliriumFemaleCohort Studiemedicine.symptomOff TreatmentbusinessSymptom controlHumanCohort studyInternal and Emergency Medicine
researchProduct

How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?

2015

Urinary bladder malignancies are uncommon in children. Approximately 80 children with papillary carcinoma have been described to date, presenting as papillary neoplasms of both low grade and low stage. On the basis of the 1973 World Health Organization classification, tumors were classified as transitional cell carcinoma of the urinary bladder (TCCB). Owing to more detailed histologic criteria, this term has been replaced by papillary urothelial neoplasm of low malignant potential and low-grade carcinoma of the urinary bladder in the World Health Organization-International Society of Urologic Pathology consensus classification system of urothelial neoplasms 2004. Nevertheless, TCCB still re…

Malemedicine.medical_specialtyPathologyAdolescentUrologyUrologyWorld Health OrganizationWorld healthmedicineCarcinomaHumansStage (cooking)ChildCarcinoma Renal CellPapillary urothelial neoplasm of low malignant potentialCarcinoma Transitional CellUrinary bladderbusiness.industryPapillary Neoplasmmedicine.diseasemedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsFemalePapillary carcinomaNeoplasm GradingbusinessUrology
researchProduct